Nrose Doctor brochure - Flipbook - Page 21
WHY INTENSE ROSE1?
Intense Rose
1
COMPETITIVENESS
• 1-1,5ML PER ONCE LABIA
• REASONABLE PRICE COMPARING TO COMPETITORS
– Product Specifications
SHORT TREATMENT TIME
PROVEN OUTCOMES
INTENSE ROSE CLINICAL STUDY SUMMARY2
Study performed on 37 PATIENTS WITH HYPOTROPHY (average age 45 years; range 36-68 years old)
100% 98%
of patients reported moderate
and sufficient elasticity
after the treatment
of patients with moderate and
sufficient elasticity after the
treatment were observed by doctors
100% 100%
of patients reported
aesthetic improvement
after the treatment
of aesthetic improvement
after the treatment
were observed by doctors
89% 98%
of patients reported
no pain during sexual
intercourse after the treatment
of patients reported no pain
during examination after the
treatment were observed by doctors
100% 97%
of patients reported moderate
and sufficient volume
after the treatment
of patients with moderate
and sufficient elasticity after the
treatment were observed by doctors
2
J. Biol Regul Homeost Agents. 2017 APR-JUN;31(2 Suppl. 2):153-161.
A new hyaluronic acid polymer in the augmentation and restoration of labia majora.
Zerbinati N1, Haddad RG2, Bader A3, Rauso R4, D’Este E5, Cipolla G5, Calligaro A6, Gonzalez P7, Salvatore S8, Serafin D9.
INJECTION PLANE
CONCENTRATION
SYRINGE
NEEDLE
CANNULA
EXTRUSION FORCE
CONTAINS
INJECTION PLANE
28 MG/ML,
PEG POLYMER CROSS-LINKED
1X1ML
21G
22G
HIGH
GLYCINE & L-PROLINE
INTRADERMAL
THERAPEUTIC EFFECT:
VULVAR ATROPHY CORRECTION AND RELATED SYMPTOMS
SPECIFIC AREA
INTIMATE AREA - LABIA MAJORA
1
This class III medical device is a regulated health product which bears, under this regulation, the CE marking. Manufacturer: MATEX LAB SPA, via Carlo Urbani
2 ang. via Enrico Fermi, Brindisi, Italy. Please carefully read the instructions in the leaflet. The use of these product requires the intervention of a healthcare
professional.
